Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28893938.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Philos+Trans+R+Soc+Lond+B+Biol+Sci 2017 ; 372 (1732): ä Nephropedia Template TP
Philos Trans R Soc Lond B Biol Sci 2017[Oct]; 372 (1732): ä PMID28893938show ga
Epstein?Barr virus (EBV), originally discovered through its association with Burkitt lymphoma, is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and malignant lymphomas of B-, T- and NK-cell origin. Some occur as rare accidents of virus persistence in the B lymphoid system, while others arise as a result of viral entry into unnatural target cells. The early finding that EBV is a potent B-cell growth transforming agent hinted at a simple oncogenic mechanism by which this virus could promote lymphomagenesis. In reality, the pathogenesis of EBV-associated lymphomas involves a complex interplay between different patterns of viral gene expression and cellular genetic changes. Here we review recent developments in our understanding of EBV-associated lymphomagenesis in both the immunocompetent and immunocompromised host.This article is part of the themed issue ?Human oncogenic viruses?.